References
1. Neidich GA, Cole SR. Gastrointestinal bleeding. Pediatr Rev 2014; 35: 243.
2. Soukoulis IW, Liang MG, Fox VL et al. Gastrointestinal Infantile Hemangioma: Presentation and Management. J Pediatr Gastroenterol Nutr 2015; 61: 415.
3. Koca T, Serdaroglu F, Dereci S, et al. Peptic Ulcers and Erosions in Children at a Pediatric Unit in Turkey. Indian Pediatr. 2016; 53(8): 692-4
4. Camus M, Jensen DM, Kovacs TO, et al. Independent risk factors of 30-day outcomes in 1264 patients with peptic ulcer bleeding in the USA: large ulcers do worse. Aliment Pharmacol Ther. 2016; 43(10): 1080-9
5. Custodio Lima J, Garcia Montes C, Kibune Nagasako C et al. Performance of the Rockall scoring system in predicting the need for intervention and outcomes in patients with nonvariceal upper gastrointestinal bleeding in a Brazilian setting: a prospective study. Digestion. 2013; 88(4): 252-7
6. Gralnek IM, Dumonceau JM, Kuipers EJ et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47(10): 1-46
7. Lanas A. Prevention of rebleeding: high-dose PPIs, second-look endoscopy or both? Endoscopy. 2016; 48(8): 699-700
8. Cheng HC, Wu CT, Chen WY, et al. Risk factors determining the need for second-look endoscopy for peptic ulcer bleeding after endoscopic hemostasis and proton pump inhibitor infusion. Endosc Int Open. 2016; 4(3): 255-62
9. Bai Y, Chen DF, Wang RQ et al. Intravenous Esomeprazole for Prevention of Peptic Ulcer Rebleeding: A Randomized Trial in Chinese Patients. Adv Ther. 2015; 32(11): 1160-76
10. Lanas A, Carrera-Lasfuentes P, García-Rodríguez LA et al. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata. Scand J Gastroenterol. 2014; 49(10): 1181-90
11. Kim DS, Jung Y, Rhee HS et al.Usefulness of the Forrest Classification to Predict Artificial Ulcer Rebleeding during Second-Look Endoscopy after Endoscopic Submucosal Dissection. Clin Endosc. 2016; 49(3): 273-81
12. Gershman G, Thomson M. Practical Pediatric Gastrointestinal Endoscopy. Wiley- Blackwell; 2012: 88-94.
13. Rahman R, Nguyen DL, Sohail U, et al. Pre-endoscopic erythromycin administration in upper gastrointestinal bleeding: an updated meta-analysis and systematic review. Ann Gastroenterol. 2016; 29(3): 312-7.
14. Recio-Ramírez JM, Sánchez-Sánchez Mdel P, Peña-Ojeda JA et al. The predictive capacity of the Glasgow-Blatchford score for the risk stratification of upper gastrointestinal bleeding in an emergency department, Rev Esp Enferm Dig. 2015; 107(5): 262-7
15. El Ouali S, Barkun A, Martel M, et al. Timing of rebleeding in high-risk peptic ulcer bleeding after successful hemostasis: a systematic review. Can J Gastroenterol Hepatol. 2014; 28(10): 543-8
16. Green FW Jr, Kaplan MM, Curtis LE et al. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology.1978; 74(1): 38-43
17. Sung JJ, Suen BY, Wu JC et al. Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy. Am J Gastroenterol. 2014; 109(7): 1005-10.
18. Barkun AN, Bardou M, Kuipers EJ et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010; 19; 152(2): 101-13.
19. Thomson MA, Leton N, Belsha D. Acute upper gastrointestinal bleeding in childhood: development of the Sheffield scoring system to predict need for endoscopic therapy, J Pediatr Gastroenterol Nutr.2015; 60(5): 632-6
20. Herzig SJ, Howell MD, Ngo LH, et al. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 2009; 301(20): 2120–8.